Stay updated on Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.

Latest updates to the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check20 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedRevision: v3.4.2 has been added, and a funding-status notice was removed; these are minor site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedA government funding status notice was added. The site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check63 days agoChange DetectedAdded a glossary toggle and updated metadata to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check77 days agoChange DetectedThe page’s revision label was updated from v3.3.3 to v3.3.4; no study content, eligibility criteria, or navigation elements appear affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.